Kromatid Selected for CIRM Industry Resource Partnership Program
Kromatid says the selection expands access to high-resolution, single-cell genomic analysis for cell and gene therapy development.
Kromatid says the selection expands access to high-resolution, single-cell genomic analysis for cell and gene therapy development.